Abstract
Policy question: Do the cost and programmatic benefits of a 1p+1 schedule outweigh the potential risk of reduced disease impact related to dropping a dose?
- Population: Children aged < 5 years of age
- Intervention: Comparison(s): Reduced dose (1p+1) schedules: 3-dose (2p+1 or 3p+0) schedules
- Outcome: Invasive pneumococcal disease, pneumonia and nasopharyngeal carriage
Evidence to recommendation table
Pneumococcal disease
